Intervention not reported
Transjugular intrahepatic portosystemic shunt (6 RCTs; 392 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes transjugular intrahepatic portosystemic shunt (6 RCTs; 392… (very low certainty).
1 finding from 1 review
HR 9.44 [1.93, 62.68]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus loop diuretics (4 RCTs; 211 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics (4 RCTs; 211 participants) (very low certainty).
1 finding from 1 review
HR 1.05 [0.7, 1.69]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus paracentesis plus fluid replacement (1 RCT; 36 participants) · people with liver cirrhosis and ascites
The intervention may leads to higher aldosterone antagonists plus paracentesis plus fluid replacement (1… (low certainty).
1 finding from 1 review
HR 30.63 [5.06, 692.98]
Studies not reported
Low
Intervention not reported
Aldosterone antagonists plus loop diuretics (4 RCTs; 242 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics (4 RCTs; 242 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Paracentesis plus systemic vasoconstrictors (3 RCTs; 114 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes paracentesis plus systemic vasoconstrictors (3 RCTs; 114 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Paracentesis plus systemic vasoconstrictors (5 RCTs; 165 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes paracentesis plus systemic vasoconstrictors (5 RCTs; 165 participants) (very low certainty).
1 finding from 1 review
HR 1.64 [0.46, 6.32]
Studies not reported
Very low
Intervention not reported
Aldosterone antagonists plus loop diuretics plus paracentesis plus fluid replacement (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes aldosterone antagonists plus loop diuretics plus paracentesis plus… (very low certainty).
1 finding from 1 review
HR 1.24 [0.62, 2.59]
Studies not reported
Very low
Intervention not reported
Transjugular intrahepatic portosystemic shunt (7 RCTs; 452 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes transjugular intrahepatic portosystemic shunt (7 RCTs; 452… (very low certainty).
1 finding from 1 review
HR 0.84 [0.6, 1.18]
Studies not reported
Very low
Intervention not reported
No active treatment (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes no active treatment (No direct RCT) (very low certainty).
1 finding from 1 review
HR 1.66 [0.46, 6.99]
Studies not reported
Very low
Intervention not reported
Loop diuretics (No direct RCT) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes loop diuretics (No direct RCT) (very low certainty).
1 finding from 1 review
HR 0.71 [0.23, 2.16]
Studies not reported
Very low
Intervention not reported
Paracentesis plus reinfusion (1 RCT; 24 participants) · people with liver cirrhosis and ascites
It is very uncertain whether the intervention changes paracentesis plus reinfusion (1 RCT; 24 participants) (very low certainty).
1 finding from 1 review
HR 0.77 [0.23, 2.68]
Studies not reported
Very low
Intervention not reported
Interventions · people with liver cirrhosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Rifaximin (1 RCT, 299 participants) · people with liver cirrhosis
It is very uncertain whether the intervention changes rifaximin (1 RCT, 299 participants) (very low certainty).
1 finding from 1 review
OR 1.01 [0, 853.21]
Studies not reported
Very low
Intervention not reported
Norfloxacin (no direct RCT) · people with liver cirrhosis
It is very uncertain whether the intervention changes norfloxacin (no direct RCT) (very low certainty).
1 finding from 1 review
OR 11.85
Studies not reported
Very low
Intervention not reported
Rifaximin (3 RCTs, 418 participants) · people with liver cirrhosis
It is very uncertain whether the intervention changes rifaximin (3 RCTs, 418 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Ciprofloxacin (3 RCT; 255 participants) · people with liver cirrhosis
It is very uncertain whether the intervention changes ciprofloxacin (3 RCT; 255 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Norfloxacin (1 RCT, 68 participants) · people with liver cirrhosis
It is very uncertain whether the intervention changes norfloxacin (1 RCT, 68 participants) (very low certainty).
1 finding from 1 review
HR 0.93 [0.31, 3.44]
Studies not reported
Very low
Intervention not reported
Ciprofloxacin (no direct RCT) · people with liver cirrhosis
It is very uncertain whether the intervention changes ciprofloxacin (no direct RCT) (very low certainty).
1 finding from 1 review
HR 0.62 [0.12, 3.31]
Studies not reported
Very low
Intervention not reported
Rifaximin (2 RCTs, 106 participants) · people with liver cirrhosis
It is very uncertain whether the intervention changes rifaximin (2 RCTs, 106 participants) (very low certainty).
1 finding from 1 review
HR 7.8 [0.13, 4647.11]
Studies not reported
Very low
Intervention not reported
Norfloxacin (3 RCTs, 255 participants) · people with liver cirrhosis
It is very uncertain whether the intervention changes norfloxacin (3 RCTs, 255 participants) (very low certainty).
1 finding from 1 review
HR 0.16 [0, 1.56]
Studies not reported
Very low